Braidwell LP Guardant Health, Inc. Transaction History
Braidwell LP
- $1.63 Billion
- Q1 2025
A detailed history of Braidwell LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Braidwell LP holds 1,327,327 shares of GH stock, worth $73.1 Million. This represents 3.47% of its overall portfolio holdings.
Number of Shares
1,327,327
Previous 2,847,931
53.39%
Holding current value
$73.1 Million
Previous $87 Million
35.01%
% of portfolio
3.47%
Previous 4.87%
Shares
8 transactions
Others Institutions Holding GH
# of Institutions
405Shares Held
128MCall Options Held
1.51MPut Options Held
2.44M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$300 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...